Shopping Cart 0
Cart Subtotal
USD 0

Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2980

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 5000

Details

Global artificial intelligence (AI) in drug discovery market will reach USD 2.57 billion by 2026, growing by 30.3% annually over 2020-2026 despite the COVID-19 impact.

Highlighted with 86 tables and 86 figures, this 178-page report Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

o Market Structure

o Growth Drivers

o Restraints and Challenges

o Emerging Product Trends & Market Opportunities

o Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region.

Based on offering, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Software

o Service

Based on technology, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Deep Learning

o Supervised Learning

o Reinforcement Learning

o Unsupervised Learning

o Other Technologies

Based on drug type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Large-molecule Drugs

o Small-molecular Drugs

Based on therapeutic area, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Oncology

o Neurodegenerative Diseases

o Cardiovascular Disease

o Metabolic Diseases

o Other Therapeutic Areas

Based on application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Information & Data Analysis

o Drug Design

o Drug Evaluation

o Clinical Trials

o Other Applications

Based on end user, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Pharmaceutical & Biotechnology Companies

o Academic & Research Institutes

o Contract Research Organizations

Geographically, the following regions together with the listed national/local markets are fully investigated:

o APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

o Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

o North America (U.S., Canada, and Mexico)

o South America (Brazil, Chile, Argentina, Rest of South America)

o RoW (Saudi Arabia, UAE, Egypt)

For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global AI in drug discovery market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Atomwise, Inc.

BenevolentAI

Berg LLC

Bioage

BIOAGE

Cloud Pharmaceuticals, Inc.

Cyclica

Deep Genomics

Envisagenics

Exscientia

Google

IBM Corporation

Insilico Medicine

Microsoft Corporation

Numedii, Inc.

Numerate

NVIDIA Corporation

Owkin, Inc.

Twoxar, Incorporated

Verge Genomics

Xtalpi, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

READ MORE

Table Of Content

Scope

1 Introduction 10

1.1 Industry Definition and Research Scope 10

1.1.1 Industry Definition 10

1.1.2 Research Scope 11

1.2 Research Methodology 14

1.2.1 Overview of Market Research Methodology 14

1.2.2 Market Assumption 15

1.2.3 Secondary Data 15

1.2.4 Primary Data 15

1.2.5 Data Filtration and Model Design 17

1.2.6 Market Size/Share Estimation 18

1.2.7 Research Limitations 19

1.3 Executive Summary 20

2 Market Overview and Dynamics 23

2.1 Market Size and Forecast 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 28

2.4 Emerging Opportunities and Market Trends 31

2.5 Porter's Fiver Forces Analysis 35

3 Segmentation of Global Market by Offering 39

3.1 Market Overview by Offering 39

3.2 Software 41

3.3 Service 42

4 Segmentation of Global Market by Technology 43

4.1 Market Overview by Technology 43

4.2 Deep Learning 45

4.3 Supervised Learning 46

4.4 Reinforcement Learning 47

4.5 Unsupervised Learning 48

4.6 Other Technologies 49

5 Segmentation of Global Market by Drug Type 50

5.1 Market Overview by Drug Type 50

5.2 Large-molecule Drugs 52

5.3 Small-molecular Drugs 53

6 Segmentation of Global Market by Therapeutic Area 54

6.1 Market Overview by Therapeutic Area 54

6.2 Oncology 57

6.3 Neurodegenerative Diseases 58

6.4 Cardiovascular Disease 59

6.5 Metabolic Diseases 60

6.6 Other Therapeutic Areas 61

7 Segmentation of Global Market by Application 62

7.1 Market Overview by Application 62

7.2 Information & Data Analysis 64

7.3 Drug Design 65

7.4 Drug Evaluation 66

7.5 Clinical Trials 67

7.6 Other Applications 68

8 Segmentation of Global Market by End User 69

8.1 Market Overview by End User 69

8.2 Pharmaceutical & Biotechnology Companies 71

8.3 Academic & Research Institutes 72

8.4 Contract Research Organizations 73

9 Segmentation of Global Market by Region 74

9.1 Geographic Market Overview 2019-2026 74

9.2 North America Market 2019-2026 by Country 78

9.2.1 Overview of North America Market 78

9.2.2 U.S. 82

9.2.3 Canada 86

9.2.4 Mexico 88

9.3 European Market 2019-2026 by Country 90

9.3.1 Overview of European Market 90

9.3.2 UK 94

9.3.3 France 96

9.3.4 Germany 98

9.3.5 Spain 100

9.3.6 Italy 102

9.3.7 Russia 104

9.3.8 Rest of European Market 106

9.4 Asia-Pacific Market 2019-2026 by Country 108

9.4.1 Overview of Asia-Pacific Market 108

9.4.2 China 111

9.4.3 Japan 113

9.4.4 India 116

9.4.5 Australia 118

9.4.6 South Korea 120

9.4.7 Rest of APAC Region 122

9.5 South America Market 2019-2026 by Country 124

9.5.1 Argentina 127

9.5.2 Brazil 129

9.5.3 Chile 131

9.5.4 Rest of South America Market 133

9.6 Rest of World Market 2019-2026 by Country 134

9.6.1 UAE 137

9.6.2 Saudi Arabia 139

9.6.3 Egypt 141

9.6.4 Other National Markets 143

10 Competitive Landscape 144

10.1 Overview of Key Vendors 144

10.2 New Product Launch, Partnership, Investment, and M&A 149

10.3 Company Profiles 150

Atomwise, Inc. 150

BenevolentAI 152

Berg LLC 153

Bioage 154

BIOAGE 155

Cloud Pharmaceuticals, Inc. 156

Cyclica 157

Deep Genomics 158

Envisagenics 159

Exscientia 160

Google 161

IBM Corporation 162

Insilico Medicine 163

Microsoft Corporation 164

Numedii, Inc. 165

Numerate 166

NVIDIA Corporation 167

Owkin, Inc. 168

Twoxar, Incorporated 169

Verge Genomics 170

Xtalpi, Inc. 171

11 Investing in Global Market: Risk Assessment and Management 172

11.1 Risk Evaluation of Global Market 172

11.2 Critical Success Factors (CSFs) 175

Related Reports and Products 178


List Of Figure

Figure 1. Research Method Flow Chart 14

Figure 2. Breakdown of Primary Research 16

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18

Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 20

Figure 5. Global AI in Drug Discovery Market, 2019-2026, USD mn 23

Figure 6. Primary Drivers and Impact Factors of Global AI in Drug Discovery Market 25

Figure 7. Primary Restraints and Impact Factors of Global AI in Drug Discovery Market 28

Figure 8. Investment Opportunity Analysis 32

Figure 9. Porter's Fiver Forces Analysis of Global AI in Drug Discovery Market 35

Figure 10. Breakdown of Global AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue 39

Figure 11. Contribution to Global 2020-2026 Cumulative Revenue by Offering, Value (USD mn) and Share (%) 40

Figure 12. Global AI in Drug Discovery Market: Software, 2015-2026, USD mn 41

Figure 13. Global AI in Drug Discovery Market: Service, 2015-2026, USD mn 42

Figure 14. Breakdown of Global AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue 43

Figure 15. Contribution to Global 2020-2026 Cumulative Revenue by Technology, Value (USD mn) and Share (%) 44

Figure 16. Global AI in Drug Discovery Market: Deep Learning, 2015-2026, USD mn 45

Figure 17. Global AI in Drug Discovery Market: Supervised Learning, 2015-2026, USD mn 46

Figure 18. Global AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, USD mn 47

Figure 19. Global AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, USD mn 48

Figure 20. Global AI in Drug Discovery Market: Other Technologies, 2015-2026, USD mn 49

Figure 21. Breakdown of Global AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue 50

Figure 22. Contribution to Global 2020-2026 Cumulative Revenue by Drug Type, Value (USD mn) and Share (%) 51

Figure 23. Global AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, USD mn 52

Figure 24. Global AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, USD mn 53

Figure 25. Breakdown of Global AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue 54

Figure 26. Contribution to Global 2020-2026 Cumulative Revenue by Therapeutic Area, Value (USD mn) and Share (%) 55

Figure 27. Global AI in Drug Discovery Market: Oncology, 2015-2026, USD mn 57

Figure 28. Global AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, USD mn 58

Figure 29. Global AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, USD mn 59

Figure 30. Global AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, USD mn 60

Figure 31. Global AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, USD mn 61

Figure 32. Breakdown of Global AI in Drug Discovery Market by Application, 2019-2026, % of Revenue 62

Figure 33. Contribution to Global 2020-2026 Cumulative Revenue by Application, Value (USD mn) and Share (%) 63

Figure 34. Global AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, USD mn 64

Figure 35. Global AI in Drug Discovery Market: Drug Design, 2015-2026, USD mn 65

Figure 36. Global AI in Drug Discovery Market: Drug Evaluation, 2015-2026, USD mn 66

Figure 37. Global AI in Drug Discovery Market: Clinical Trials, 2015-2026, USD mn 67

Figure 38. Global AI in Drug Discovery Market: Other Applications, 2015-2026, USD mn 68

Figure 39. Breakdown of Global AI in Drug Discovery Market by End User, 2019-2026, % of Revenue 69

Figure 40. Contribution to Global 2020-2026 Cumulative Revenue by End User, Value (USD mn) and Share (%) 70

Figure 41. Global AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, USD mn 71

Figure 42. Global AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, USD mn 72

Figure 43. Global AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, USD mn 73

Figure 44. Global Market Snapshot by Region 74

Figure 45. Geographic Spread of Worldwide AI in Drug Discovery Market, 2019-2026, % of Revenue 75

Figure 46. Contribution to Global 2020-2026 Cumulative Revenue by Region, Value (USD mn) and Share (%) 76

Figure 47. North American AI in Drug Discovery Market, 2015-2026, USD mn 79

Figure 48. Breakdown of North America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 79

Figure 49. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 80

Figure 50. U.S. AI in Drug Discovery Market, 2015-2026, USD mn 83

Figure 51. Canada AI in Drug Discovery Market, 2015-2026, USD mn 86

Figure 52. AI in Drug Discovery Market in Mexico, 2015-2026, USD mn 88

Figure 53. European AI in Drug Discovery Market, 2015-2026, USD mn 91

Figure 54. Breakdown of European AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 91

Figure 55. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 92

Figure 56. AI in Drug Discovery Market in UK, 2015-2026, USD mn 94

Figure 57. AI in Drug Discovery Market in France, 2015-2026, USD mn 96

Figure 58. AI in Drug Discovery Market in Germany, 2015-2026, USD mn 98

Figure 59. AI in Drug Discovery Market in Spain, 2015-2026, USD mn 100

Figure 60. AI in Drug Discovery Market in Italy, 2015-2026, USD mn 102

Figure 61. AI in Drug Discovery Market in Russia, 2015-2026, USD mn 104

Figure 62. AI in Drug Discovery Market in Rest of Europe, 2015-2026, USD mn 106

Figure 63. Asia-Pacific AI in Drug Discovery Market, 2015-2026, USD mn 109

Figure 64. Breakdown of APAC AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 109

Figure 65. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 110

Figure 66. AI in Drug Discovery Market in China, 2015-2026, USD mn 111

Figure 67. AI in Drug Discovery Market in Japan, 2015-2026, USD mn 114

Figure 68. AI in Drug Discovery Market in India, 2015-2026, USD mn 116

Figure 69. AI in Drug Discovery Market in Australia, 2015-2026, USD mn 118

Figure 70. AI in Drug Discovery Market in South Korea, 2015-2026, USD mn 120

Figure 71. AI in Drug Discovery Market in Rest of APAC, 2015-2026, USD mn 122

Figure 72. South America AI in Drug Discovery Market, 2015-2026, USD mn 125

Figure 73. Breakdown of South America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 125

Figure 74. Contribution to South America 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 126

Figure 75. AI in Drug Discovery Market in Argentina, 2015-2026, USD mn 127

Figure 76. AI in Drug Discovery Market in Brazil, 2015-2026, USD mn 129

Figure 77. AI in Drug Discovery Market in Chile, 2015-2026, USD mn 131

Figure 78. AI in Drug Discovery Market in Rest of South America, 2015-2026, USD mn 133

Figure 79. AI in Drug Discovery Market in Rest of the World (RoW), 2015-2026, USD mn 135

Figure 80. Breakdown of RoW AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 135

Figure 81. Contribution to RoW 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 136

Figure 82. AI in Drug Discovery Market in UAE, 2015-2026, USD mn 137

Figure 83. AI in Drug Discovery Market in Saudi Arabia, 2015-2026, USD mn 139

Figure 84. AI in Drug Discovery Market in Egypt, 2015-2026, USD mn 141

Figure 85. Growth Stage of Global AI in Drug Discovery Industry over the Forecast Period 144

Figure 86. Share of Developments of Key Vendors by Strategy Type, 2015-2019 146

 


List Of Table

Table 1. Snapshot of Global AI in Drug Discovery Market, 2019-2026 21

Table 2. Main Product Trends and Market Opportunities in Global AI in Drug Discovery Market 31

Table 3. Global AI in Drug Discovery Market by Offering, 2015-2026, USD mn 39

Table 4. Global AI in Drug Discovery Market by Technology, 2015-2026, USD mn 43

Table 5. Global AI in Drug Discovery Market by Drug Type, 2015-2026, USD mn 50

Table 6. Global AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 54

Table 7. Selected Drug Development Pipelines Aided by AI 56

Table 8. Global AI in Drug Discovery Market by Application, 2015-2026, USD mn 62

Table 9. Global AI in Drug Discovery Market by End User, 2015-2026, USD mn 69

Table 10. Global AI in Drug Discovery Market by Region, 2015-2026, USD mn 75

Table 11. Leading National AI in Drug Discovery Market, 2019 and 2026, USD mn 77

Table 12. North America AI in Drug Discovery Market by Country, 2015-2026, USD mn 80

Table 13. U.S. AI in Drug Discovery Market by Technology, 2015-2026, USD mn 84

Table 14. U.S. AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 84

Table 15. U.S. AI in Drug Discovery Market by End User, 2015-2026, USD mn 84

Table 16. Canada AI in Drug Discovery Market by Technology, 2015-2026, USD mn 87

Table 17. Canada AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 87

Table 18. Canada AI in Drug Discovery Market by End User, 2015-2026, USD mn 87

Table 19. Mexico AI in Drug Discovery Market by Technology, 2015-2026, USD mn 89

Table 20. Mexico AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 89

Table 21. Mexico AI in Drug Discovery Market by End User, 2015-2026, USD mn 89

Table 22. Europe AI in Drug Discovery Market by Country, 2015-2026, USD mn 92

Table 23. UK AI in Drug Discovery Market by Technology, 2015-2026, USD mn 95

Table 24. UK AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 95

Table 25. UK AI in Drug Discovery Market by End User, 2015-2026, USD mn 95

Table 26. France AI in Drug Discovery Market by Technology, 2015-2026, USD mn 97

Table 27. France AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 97

Table 28. France AI in Drug Discovery Market by End User, 2015-2026, USD mn 97

Table 29. Germany AI in Drug Discovery Market by Technology, 2015-2026, USD mn 99

Table 30. Germany AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 99

Table 31. Germany AI in Drug Discovery Market by End User, 2015-2026, USD mn 99

Table 32. Spain AI in Drug Discovery Market by Technology, 2015-2026, USD mn 101

Table 33. Spain AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 101

Table 34. Spain AI in Drug Discovery Market by End User, 2015-2026, USD mn 101

Table 35. Italy AI in Drug Discovery Market by Technology, 2015-2026, USD mn 103

Table 36. Italy AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 103

Table 37. Italy AI in Drug Discovery Market by End User, 2015-2026, USD mn 103

Table 38. Russia AI in Drug Discovery Market by Technology, 2015-2026, USD mn 105

Table 39. Russia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 105

Table 40. Russia AI in Drug Discovery Market by End User, 2015-2026, USD mn 105

Table 41. AI in Drug Discovery Market in Rest of Europe by Country, 2015-2026, USD mn 107

Table 42. APAC AI in Drug Discovery Market by Country, 2015-2026, USD mn 110

Table 43. China AI in Drug Discovery Market by Technology, 2015-2026, USD mn 112

Table 44. China AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 112

Table 45. China AI in Drug Discovery Market by End User, 2015-2026, USD mn 112

Table 46. Japan AI in Drug Discovery Market by Technology, 2015-2026, USD mn 115

Table 47. Japan AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 115

Table 48. Japan AI in Drug Discovery Market by End User, 2015-2026, USD mn 115

Table 49. India AI in Drug Discovery Market by Technology, 2015-2026, USD mn 117

Table 50. India AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 117

Table 51. India AI in Drug Discovery Market by End User, 2015-2026, USD mn 117

Table 52. Australia AI in Drug Discovery Market by Technology, 2015-2026, USD mn 119

Table 53. Australia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 119

Table 54. Australia AI in Drug Discovery Market by End User, 2015-2026, USD mn 119

Table 55. South Korea AI in Drug Discovery Market by Technology, 2015-2026, USD mn 121

Table 56. South Korea AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 121

Table 57. South Korea AI in Drug Discovery Market by End User, 2015-2026, USD mn 121

Table 58. AI in Drug Discovery Market in Rest of APAC by Country, 2015-2026, USD mn 123

Table 59. South America AI in Drug Discovery Market by Country, 2015-2026, USD mn 126

Table 60. Argentina AI in Drug Discovery Market by Technology, 2015-2026, USD mn 128

Table 61. Argentina AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 128

Table 62. Argentina AI in Drug Discovery Market by End User, 2015-2026, USD mn 128

Table 63. Brazil AI in Drug Discovery Market by Technology, 2015-2026, USD mn 130

Table 64. Brazil AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 130

Table 65. Brazil AI in Drug Discovery Market by End User, 2015-2026, USD mn 130

Table 66. Chile AI in Drug Discovery Market by Technology, 2015-2026, USD mn 132

Table 67. Chile AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 132

Table 68. Chile AI in Drug Discovery Market by End User, 2015-2026, USD mn 132

Table 69. RoW AI in Drug Discovery Market by Country, 2015-2026, USD mn 136

Table 70. UAE AI in Drug Discovery Market by Technology, 2015-2026, USD mn 138

Table 71. UAE AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 138

Table 72. UAE AI in Drug Discovery Market by End User, 2015-2026, USD mn 138

Table 73. Saudi Arabia AI in Drug Discovery Market by Technology, 2015-2026, USD mn 140

Table 74. Saudi Arabia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 140

Table 75. Saudi Arabia AI in Drug Discovery Market by End User, 2015-2026, USD mn 140

Table 76. Egypt AI in Drug Discovery Market by Technology, 2015-2026, USD mn 142

Table 77. Egypt AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 142

Table 78. Egypt AI in Drug Discovery Market by End User, 2015-2026, USD mn 142

Table 79. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies 147

Table 80. Atomwise, Inc.: Company Snapshot 150

Table 81. Atomwise, Inc.: Business Segmentation 150

Table 82. Atomwise, Inc.: Product Portfolio 151

Table 83. Atomwise, Inc.: Revenue, 2016-2018, USD mn 151

Table 84. Atomwise, Inc.: Recent Developments 151

Table 85. Risk Evaluation for Investing in Global Market, 2019-2026 173

Table 86. Critical Success Factors and Key Takeaways 176

 

 

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Atomwise, Inc.

BenevolentAI

Berg LLC

Bioage

BIOAGE

Cloud Pharmaceuticals, Inc.

Cyclica

Deep Genomics

Envisagenics

Exscientia

Google

IBM Corporation

Insilico Medicine

Microsoft Corporation

Numedii, Inc.

Numerate

NVIDIA Corporation

Owkin, Inc.

Twoxar, Incorporated

Verge Genomics

Xtalpi, Inc.

Company Profile

Company Profile Title

Global artificial intelligence (AI) in drug discovery market will reach USD 2.57 billion by 2026, growing by 30.3% annually over 2020-2026 despite the COVID-19 impact.

Highlighted with 86 tables and 86 figures, this 178-page report Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

o Market Structure

o Growth Drivers

o Restraints and Challenges

o Emerging Product Trends & Market Opportunities

o Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region.

Based on offering, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Software

o Service

Based on technology, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Deep Learning

o Supervised Learning

o Reinforcement Learning

o Unsupervised Learning

o Other Technologies

Based on drug type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Large-molecule Drugs

o Small-molecular Drugs

Based on therapeutic area, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Oncology

o Neurodegenerative Diseases

o Cardiovascular Disease

o Metabolic Diseases

o Other Therapeutic Areas

Based on application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Information & Data Analysis

o Drug Design

o Drug Evaluation

o Clinical Trials

o Other Applications

Based on end user, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Pharmaceutical & Biotechnology Companies

o Academic & Research Institutes

o Contract Research Organizations

Geographically, the following regions together with the listed national/local markets are fully investigated:

o APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

o Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

o North America (U.S., Canada, and Mexico)

o South America (Brazil, Chile, Argentina, Rest of South America)

o RoW (Saudi Arabia, UAE, Egypt)

For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global AI in drug discovery market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Atomwise, Inc.

BenevolentAI

Berg LLC

Bioage

BIOAGE

Cloud Pharmaceuticals, Inc.

Cyclica

Deep Genomics

Envisagenics

Exscientia

Google

IBM Corporation

Insilico Medicine

Microsoft Corporation

Numedii, Inc.

Numerate

NVIDIA Corporation

Owkin, Inc.

Twoxar, Incorporated

Verge Genomics

Xtalpi, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

READ MORE

Scope

1 Introduction 10

1.1 Industry Definition and Research Scope 10

1.1.1 Industry Definition 10

1.1.2 Research Scope 11

1.2 Research Methodology 14

1.2.1 Overview of Market Research Methodology 14

1.2.2 Market Assumption 15

1.2.3 Secondary Data 15

1.2.4 Primary Data 15

1.2.5 Data Filtration and Model Design 17

1.2.6 Market Size/Share Estimation 18

1.2.7 Research Limitations 19

1.3 Executive Summary 20

2 Market Overview and Dynamics 23

2.1 Market Size and Forecast 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 28

2.4 Emerging Opportunities and Market Trends 31

2.5 Porter's Fiver Forces Analysis 35

3 Segmentation of Global Market by Offering 39

3.1 Market Overview by Offering 39

3.2 Software 41

3.3 Service 42

4 Segmentation of Global Market by Technology 43

4.1 Market Overview by Technology 43

4.2 Deep Learning 45

4.3 Supervised Learning 46

4.4 Reinforcement Learning 47

4.5 Unsupervised Learning 48

4.6 Other Technologies 49

5 Segmentation of Global Market by Drug Type 50

5.1 Market Overview by Drug Type 50

5.2 Large-molecule Drugs 52

5.3 Small-molecular Drugs 53

6 Segmentation of Global Market by Therapeutic Area 54

6.1 Market Overview by Therapeutic Area 54

6.2 Oncology 57

6.3 Neurodegenerative Diseases 58

6.4 Cardiovascular Disease 59

6.5 Metabolic Diseases 60

6.6 Other Therapeutic Areas 61

7 Segmentation of Global Market by Application 62

7.1 Market Overview by Application 62

7.2 Information & Data Analysis 64

7.3 Drug Design 65

7.4 Drug Evaluation 66

7.5 Clinical Trials 67

7.6 Other Applications 68

8 Segmentation of Global Market by End User 69

8.1 Market Overview by End User 69

8.2 Pharmaceutical & Biotechnology Companies 71

8.3 Academic & Research Institutes 72

8.4 Contract Research Organizations 73

9 Segmentation of Global Market by Region 74

9.1 Geographic Market Overview 2019-2026 74

9.2 North America Market 2019-2026 by Country 78

9.2.1 Overview of North America Market 78

9.2.2 U.S. 82

9.2.3 Canada 86

9.2.4 Mexico 88

9.3 European Market 2019-2026 by Country 90

9.3.1 Overview of European Market 90

9.3.2 UK 94

9.3.3 France 96

9.3.4 Germany 98

9.3.5 Spain 100

9.3.6 Italy 102

9.3.7 Russia 104

9.3.8 Rest of European Market 106

9.4 Asia-Pacific Market 2019-2026 by Country 108

9.4.1 Overview of Asia-Pacific Market 108

9.4.2 China 111

9.4.3 Japan 113

9.4.4 India 116

9.4.5 Australia 118

9.4.6 South Korea 120

9.4.7 Rest of APAC Region 122

9.5 South America Market 2019-2026 by Country 124

9.5.1 Argentina 127

9.5.2 Brazil 129

9.5.3 Chile 131

9.5.4 Rest of South America Market 133

9.6 Rest of World Market 2019-2026 by Country 134

9.6.1 UAE 137

9.6.2 Saudi Arabia 139

9.6.3 Egypt 141

9.6.4 Other National Markets 143

10 Competitive Landscape 144

10.1 Overview of Key Vendors 144

10.2 New Product Launch, Partnership, Investment, and M&A 149

10.3 Company Profiles 150

Atomwise, Inc. 150

BenevolentAI 152

Berg LLC 153

Bioage 154

BIOAGE 155

Cloud Pharmaceuticals, Inc. 156

Cyclica 157

Deep Genomics 158

Envisagenics 159

Exscientia 160

Google 161

IBM Corporation 162

Insilico Medicine 163

Microsoft Corporation 164

Numedii, Inc. 165

Numerate 166

NVIDIA Corporation 167

Owkin, Inc. 168

Twoxar, Incorporated 169

Verge Genomics 170

Xtalpi, Inc. 171

11 Investing in Global Market: Risk Assessment and Management 172

11.1 Risk Evaluation of Global Market 172

11.2 Critical Success Factors (CSFs) 175

Related Reports and Products 178


List Of Figure

Figure 1. Research Method Flow Chart 14

Figure 2. Breakdown of Primary Research 16

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18

Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 20

Figure 5. Global AI in Drug Discovery Market, 2019-2026, USD mn 23

Figure 6. Primary Drivers and Impact Factors of Global AI in Drug Discovery Market 25

Figure 7. Primary Restraints and Impact Factors of Global AI in Drug Discovery Market 28

Figure 8. Investment Opportunity Analysis 32

Figure 9. Porter's Fiver Forces Analysis of Global AI in Drug Discovery Market 35

Figure 10. Breakdown of Global AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue 39

Figure 11. Contribution to Global 2020-2026 Cumulative Revenue by Offering, Value (USD mn) and Share (%) 40

Figure 12. Global AI in Drug Discovery Market: Software, 2015-2026, USD mn 41

Figure 13. Global AI in Drug Discovery Market: Service, 2015-2026, USD mn 42

Figure 14. Breakdown of Global AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue 43

Figure 15. Contribution to Global 2020-2026 Cumulative Revenue by Technology, Value (USD mn) and Share (%) 44

Figure 16. Global AI in Drug Discovery Market: Deep Learning, 2015-2026, USD mn 45

Figure 17. Global AI in Drug Discovery Market: Supervised Learning, 2015-2026, USD mn 46

Figure 18. Global AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, USD mn 47

Figure 19. Global AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, USD mn 48

Figure 20. Global AI in Drug Discovery Market: Other Technologies, 2015-2026, USD mn 49

Figure 21. Breakdown of Global AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue 50

Figure 22. Contribution to Global 2020-2026 Cumulative Revenue by Drug Type, Value (USD mn) and Share (%) 51

Figure 23. Global AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, USD mn 52

Figure 24. Global AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, USD mn 53

Figure 25. Breakdown of Global AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue 54

Figure 26. Contribution to Global 2020-2026 Cumulative Revenue by Therapeutic Area, Value (USD mn) and Share (%) 55

Figure 27. Global AI in Drug Discovery Market: Oncology, 2015-2026, USD mn 57

Figure 28. Global AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, USD mn 58

Figure 29. Global AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, USD mn 59

Figure 30. Global AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, USD mn 60

Figure 31. Global AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, USD mn 61

Figure 32. Breakdown of Global AI in Drug Discovery Market by Application, 2019-2026, % of Revenue 62

Figure 33. Contribution to Global 2020-2026 Cumulative Revenue by Application, Value (USD mn) and Share (%) 63

Figure 34. Global AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, USD mn 64

Figure 35. Global AI in Drug Discovery Market: Drug Design, 2015-2026, USD mn 65

Figure 36. Global AI in Drug Discovery Market: Drug Evaluation, 2015-2026, USD mn 66

Figure 37. Global AI in Drug Discovery Market: Clinical Trials, 2015-2026, USD mn 67

Figure 38. Global AI in Drug Discovery Market: Other Applications, 2015-2026, USD mn 68

Figure 39. Breakdown of Global AI in Drug Discovery Market by End User, 2019-2026, % of Revenue 69

Figure 40. Contribution to Global 2020-2026 Cumulative Revenue by End User, Value (USD mn) and Share (%) 70

Figure 41. Global AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, USD mn 71

Figure 42. Global AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, USD mn 72

Figure 43. Global AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, USD mn 73

Figure 44. Global Market Snapshot by Region 74

Figure 45. Geographic Spread of Worldwide AI in Drug Discovery Market, 2019-2026, % of Revenue 75

Figure 46. Contribution to Global 2020-2026 Cumulative Revenue by Region, Value (USD mn) and Share (%) 76

Figure 47. North American AI in Drug Discovery Market, 2015-2026, USD mn 79

Figure 48. Breakdown of North America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 79

Figure 49. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 80

Figure 50. U.S. AI in Drug Discovery Market, 2015-2026, USD mn 83

Figure 51. Canada AI in Drug Discovery Market, 2015-2026, USD mn 86

Figure 52. AI in Drug Discovery Market in Mexico, 2015-2026, USD mn 88

Figure 53. European AI in Drug Discovery Market, 2015-2026, USD mn 91

Figure 54. Breakdown of European AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 91

Figure 55. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 92

Figure 56. AI in Drug Discovery Market in UK, 2015-2026, USD mn 94

Figure 57. AI in Drug Discovery Market in France, 2015-2026, USD mn 96

Figure 58. AI in Drug Discovery Market in Germany, 2015-2026, USD mn 98

Figure 59. AI in Drug Discovery Market in Spain, 2015-2026, USD mn 100

Figure 60. AI in Drug Discovery Market in Italy, 2015-2026, USD mn 102

Figure 61. AI in Drug Discovery Market in Russia, 2015-2026, USD mn 104

Figure 62. AI in Drug Discovery Market in Rest of Europe, 2015-2026, USD mn 106

Figure 63. Asia-Pacific AI in Drug Discovery Market, 2015-2026, USD mn 109

Figure 64. Breakdown of APAC AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 109

Figure 65. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 110

Figure 66. AI in Drug Discovery Market in China, 2015-2026, USD mn 111

Figure 67. AI in Drug Discovery Market in Japan, 2015-2026, USD mn 114

Figure 68. AI in Drug Discovery Market in India, 2015-2026, USD mn 116

Figure 69. AI in Drug Discovery Market in Australia, 2015-2026, USD mn 118

Figure 70. AI in Drug Discovery Market in South Korea, 2015-2026, USD mn 120

Figure 71. AI in Drug Discovery Market in Rest of APAC, 2015-2026, USD mn 122

Figure 72. South America AI in Drug Discovery Market, 2015-2026, USD mn 125

Figure 73. Breakdown of South America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 125

Figure 74. Contribution to South America 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 126

Figure 75. AI in Drug Discovery Market in Argentina, 2015-2026, USD mn 127

Figure 76. AI in Drug Discovery Market in Brazil, 2015-2026, USD mn 129

Figure 77. AI in Drug Discovery Market in Chile, 2015-2026, USD mn 131

Figure 78. AI in Drug Discovery Market in Rest of South America, 2015-2026, USD mn 133

Figure 79. AI in Drug Discovery Market in Rest of the World (RoW), 2015-2026, USD mn 135

Figure 80. Breakdown of RoW AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 135

Figure 81. Contribution to RoW 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 136

Figure 82. AI in Drug Discovery Market in UAE, 2015-2026, USD mn 137

Figure 83. AI in Drug Discovery Market in Saudi Arabia, 2015-2026, USD mn 139

Figure 84. AI in Drug Discovery Market in Egypt, 2015-2026, USD mn 141

Figure 85. Growth Stage of Global AI in Drug Discovery Industry over the Forecast Period 144

Figure 86. Share of Developments of Key Vendors by Strategy Type, 2015-2019 146

 


List Of Table

Table 1. Snapshot of Global AI in Drug Discovery Market, 2019-2026 21

Table 2. Main Product Trends and Market Opportunities in Global AI in Drug Discovery Market 31

Table 3. Global AI in Drug Discovery Market by Offering, 2015-2026, USD mn 39

Table 4. Global AI in Drug Discovery Market by Technology, 2015-2026, USD mn 43

Table 5. Global AI in Drug Discovery Market by Drug Type, 2015-2026, USD mn 50

Table 6. Global AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 54

Table 7. Selected Drug Development Pipelines Aided by AI 56

Table 8. Global AI in Drug Discovery Market by Application, 2015-2026, USD mn 62

Table 9. Global AI in Drug Discovery Market by End User, 2015-2026, USD mn 69

Table 10. Global AI in Drug Discovery Market by Region, 2015-2026, USD mn 75

Table 11. Leading National AI in Drug Discovery Market, 2019 and 2026, USD mn 77

Table 12. North America AI in Drug Discovery Market by Country, 2015-2026, USD mn 80

Table 13. U.S. AI in Drug Discovery Market by Technology, 2015-2026, USD mn 84

Table 14. U.S. AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 84

Table 15. U.S. AI in Drug Discovery Market by End User, 2015-2026, USD mn 84

Table 16. Canada AI in Drug Discovery Market by Technology, 2015-2026, USD mn 87

Table 17. Canada AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 87

Table 18. Canada AI in Drug Discovery Market by End User, 2015-2026, USD mn 87

Table 19. Mexico AI in Drug Discovery Market by Technology, 2015-2026, USD mn 89

Table 20. Mexico AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 89

Table 21. Mexico AI in Drug Discovery Market by End User, 2015-2026, USD mn 89

Table 22. Europe AI in Drug Discovery Market by Country, 2015-2026, USD mn 92

Table 23. UK AI in Drug Discovery Market by Technology, 2015-2026, USD mn 95

Table 24. UK AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 95

Table 25. UK AI in Drug Discovery Market by End User, 2015-2026, USD mn 95

Table 26. France AI in Drug Discovery Market by Technology, 2015-2026, USD mn 97

Table 27. France AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 97

Table 28. France AI in Drug Discovery Market by End User, 2015-2026, USD mn 97

Table 29. Germany AI in Drug Discovery Market by Technology, 2015-2026, USD mn 99

Table 30. Germany AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 99

Table 31. Germany AI in Drug Discovery Market by End User, 2015-2026, USD mn 99

Table 32. Spain AI in Drug Discovery Market by Technology, 2015-2026, USD mn 101

Table 33. Spain AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 101

Table 34. Spain AI in Drug Discovery Market by End User, 2015-2026, USD mn 101

Table 35. Italy AI in Drug Discovery Market by Technology, 2015-2026, USD mn 103

Table 36. Italy AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 103

Table 37. Italy AI in Drug Discovery Market by End User, 2015-2026, USD mn 103

Table 38. Russia AI in Drug Discovery Market by Technology, 2015-2026, USD mn 105

Table 39. Russia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 105

Table 40. Russia AI in Drug Discovery Market by End User, 2015-2026, USD mn 105

Table 41. AI in Drug Discovery Market in Rest of Europe by Country, 2015-2026, USD mn 107

Table 42. APAC AI in Drug Discovery Market by Country, 2015-2026, USD mn 110

Table 43. China AI in Drug Discovery Market by Technology, 2015-2026, USD mn 112

Table 44. China AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 112

Table 45. China AI in Drug Discovery Market by End User, 2015-2026, USD mn 112

Table 46. Japan AI in Drug Discovery Market by Technology, 2015-2026, USD mn 115

Table 47. Japan AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 115

Table 48. Japan AI in Drug Discovery Market by End User, 2015-2026, USD mn 115

Table 49. India AI in Drug Discovery Market by Technology, 2015-2026, USD mn 117

Table 50. India AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 117

Table 51. India AI in Drug Discovery Market by End User, 2015-2026, USD mn 117

Table 52. Australia AI in Drug Discovery Market by Technology, 2015-2026, USD mn 119

Table 53. Australia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 119

Table 54. Australia AI in Drug Discovery Market by End User, 2015-2026, USD mn 119

Table 55. South Korea AI in Drug Discovery Market by Technology, 2015-2026, USD mn 121

Table 56. South Korea AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 121

Table 57. South Korea AI in Drug Discovery Market by End User, 2015-2026, USD mn 121

Table 58. AI in Drug Discovery Market in Rest of APAC by Country, 2015-2026, USD mn 123

Table 59. South America AI in Drug Discovery Market by Country, 2015-2026, USD mn 126

Table 60. Argentina AI in Drug Discovery Market by Technology, 2015-2026, USD mn 128

Table 61. Argentina AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 128

Table 62. Argentina AI in Drug Discovery Market by End User, 2015-2026, USD mn 128

Table 63. Brazil AI in Drug Discovery Market by Technology, 2015-2026, USD mn 130

Table 64. Brazil AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 130

Table 65. Brazil AI in Drug Discovery Market by End User, 2015-2026, USD mn 130

Table 66. Chile AI in Drug Discovery Market by Technology, 2015-2026, USD mn 132

Table 67. Chile AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 132

Table 68. Chile AI in Drug Discovery Market by End User, 2015-2026, USD mn 132

Table 69. RoW AI in Drug Discovery Market by Country, 2015-2026, USD mn 136

Table 70. UAE AI in Drug Discovery Market by Technology, 2015-2026, USD mn 138

Table 71. UAE AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 138

Table 72. UAE AI in Drug Discovery Market by End User, 2015-2026, USD mn 138

Table 73. Saudi Arabia AI in Drug Discovery Market by Technology, 2015-2026, USD mn 140

Table 74. Saudi Arabia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 140

Table 75. Saudi Arabia AI in Drug Discovery Market by End User, 2015-2026, USD mn 140

Table 76. Egypt AI in Drug Discovery Market by Technology, 2015-2026, USD mn 142

Table 77. Egypt AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 142

Table 78. Egypt AI in Drug Discovery Market by End User, 2015-2026, USD mn 142

Table 79. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies 147

Table 80. Atomwise, Inc.: Company Snapshot 150

Table 81. Atomwise, Inc.: Business Segmentation 150

Table 82. Atomwise, Inc.: Product Portfolio 151

Table 83. Atomwise, Inc.: Revenue, 2016-2018, USD mn 151

Table 84. Atomwise, Inc.: Recent Developments 151

Table 85. Risk Evaluation for Investing in Global Market, 2019-2026 173

Table 86. Critical Success Factors and Key Takeaways 176

 

 

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Atomwise, Inc.

BenevolentAI

Berg LLC

Bioage

BIOAGE

Cloud Pharmaceuticals, Inc.

Cyclica

Deep Genomics

Envisagenics

Exscientia

Google

IBM Corporation

Insilico Medicine

Microsoft Corporation

Numedii, Inc.

Numerate

NVIDIA Corporation

Owkin, Inc.

Twoxar, Incorporated

Verge Genomics

Xtalpi, Inc.